| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antitumor activity of edotecarin in breast carcinoma models
|
Ciomei, Marina
|
|
|
60 |
2 |
p. 229-235
|
article
|
| 2 |
Antitumor activity of edotecarin in breast carcinoma models
|
Ciomei, Marina
|
|
2006
|
60 |
2 |
p. 229-235
|
article
|
| 3 |
Apoptosis induced by ID6105, a new anthracycline (11-hydroxyaclacinomycin X, Hyrubicin), and its anti-tumor effects on experimental tumor models
|
Lee, Hong Sub
|
|
|
60 |
2 |
|
article
|
| 4 |
Apoptosis induced by ID6105, a new anthracycline (11-hydroxyaclacinomycin X, Hyrubicin), and its anti-tumor effects on experimental tumor models
|
Lee, Hong Sub
|
|
2006
|
60 |
2 |
p. 197-201
|
article
|
| 5 |
Bortezomib activity and in vitro interactions with anthracyclines and cytarabine in acute myeloid leukemia cells are independent of multidrug resistance mechanisms and p53 status
|
Minderman, Hans
|
|
|
60 |
2 |
p. 245-255
|
article
|
| 6 |
Bortezomib activity and in vitro interactions with anthracyclines and cytarabine in acute myeloid leukemia cells are independent of multidrug resistance mechanisms and p53 status
|
Minderman, Hans
|
|
2006
|
60 |
2 |
p. 245-255
|
article
|
| 7 |
Challenges for patient selection with VEGF inhibitors
|
Longo, R.
|
|
|
60 |
2 |
p. 151-170
|
article
|
| 8 |
Challenges for patient selection with VEGF inhibitors
|
Longo, R.
|
|
2007
|
60 |
2 |
p. 151-170
|
article
|
| 9 |
Comparative nephrotoxicity of cisplatin and new octahedral Pt(IV) complexes
|
Kim, Won-Kyu
|
|
|
60 |
2 |
p. 237-243
|
article
|
| 10 |
Comparative nephrotoxicity of cisplatin and new octahedral Pt(IV) complexes
|
Kim, Won-Kyu
|
|
2006
|
60 |
2 |
p. 237-243
|
article
|
| 11 |
Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine
|
Marczylo, Timothy H.
|
|
|
60 |
2 |
p. 171-177
|
article
|
| 12 |
Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine
|
Marczylo, Timothy H.
|
|
2006
|
60 |
2 |
p. 171-177
|
article
|
| 13 |
Dexamethasone as a probe for CYP3A4 metabolism: evidence of gender effect
|
Puisset, F.
|
|
|
60 |
2 |
p. 305-308
|
article
|
| 14 |
Dexamethasone as a probe for CYP3A4 metabolism: evidence of gender effect
|
Puisset, F.
|
|
2006
|
60 |
2 |
p. 305-308
|
article
|
| 15 |
Differential effects of the immunosuppressive agents cyclosporin A, tacrolimus and sirolimus on drug transport by multidrug resistance proteins
|
Pawarode, Attaphol
|
|
|
60 |
2 |
p. 179-188
|
article
|
| 16 |
Differential effects of the immunosuppressive agents cyclosporin A, tacrolimus and sirolimus on drug transport by multidrug resistance proteins
|
Pawarode, Attaphol
|
|
2006
|
60 |
2 |
p. 179-188
|
article
|
| 17 |
Erlotinib plus gemcitabine in patients with unresectable pancreatic cancer and other solid tumors: phase IB trial
|
Dragovich, Tomislav
|
|
|
60 |
2 |
p. 295-303
|
article
|
| 18 |
Erlotinib plus gemcitabine in patients with unresectable pancreatic cancer and other solid tumors: phase IB trial
|
Dragovich, Tomislav
|
|
2006
|
60 |
2 |
p. 295-303
|
article
|
| 19 |
Induction of oxidative damage by copper-based antineoplastic drugs (Casiopeínas®)
|
Alemón-Medina, Radamés
|
|
|
60 |
2 |
p. 219-228
|
article
|
| 20 |
Induction of oxidative damage by copper-based antineoplastic drugs (Casiopeínas®)
|
Alemón-Medina, Radamés
|
|
2007
|
60 |
2 |
p. 219-228
|
article
|
| 21 |
Phase II study of biweekly administration of docetaxel and irinotecan in patients with refractory or relapsed advanced non-small cell lung cancer
|
Hirose, Takashi
|
|
|
60 |
2 |
p. 267-274
|
article
|
| 22 |
Phase II study of biweekly administration of docetaxel and irinotecan in patients with refractory or relapsed advanced non-small cell lung cancer
|
Hirose, Takashi
|
|
2007
|
60 |
2 |
p. 267-274
|
article
|
| 23 |
Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy
|
Mori, Kiyoshi
|
|
|
60 |
2 |
p. 189-195
|
article
|
| 24 |
Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy
|
Mori, Kiyoshi
|
|
2006
|
60 |
2 |
p. 189-195
|
article
|
| 25 |
Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, which was administered to patients with advanced solid tumors on days 1 and 8 in 3-week courses
|
Tamura, Kenji
|
|
|
60 |
2 |
p. 285-293
|
article
|
| 26 |
Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, which was administered to patients with advanced solid tumors on days 1 and 8 in 3-week courses
|
Tamura, Kenji
|
|
2006
|
60 |
2 |
p. 285-293
|
article
|
| 27 |
Phase I trial of oral MAC-321 in subjects with advanced malignant solid tumors
|
Lockhart, A. C.
|
|
|
60 |
2 |
p. 203-209
|
article
|
| 28 |
Phase I trial of oral MAC-321 in subjects with advanced malignant solid tumors
|
Lockhart, A. C.
|
|
2006
|
60 |
2 |
p. 203-209
|
article
|
| 29 |
The efficacy and relationship between peak concentration and toxicity profile of fixed-dose-rate gemcitabine plus carboplatin in patients with advanced non-small-cell lung cancer
|
Wang, Linrun
|
|
|
60 |
2 |
p. 211-218
|
article
|
| 30 |
The efficacy and relationship between peak concentration and toxicity profile of fixed-dose-rate gemcitabine plus carboplatin in patients with advanced non-small-cell lung cancer
|
Wang, Linrun
|
|
2006
|
60 |
2 |
p. 211-218
|
article
|
| 31 |
The histone deacetylase inhibitor PXD101 synergises with 5-fluorouracil to inhibit colon cancer cell growth in vitro and in vivo
|
Tumber, Anthony
|
|
|
60 |
2 |
p. 275-283
|
article
|
| 32 |
The histone deacetylase inhibitor PXD101 synergises with 5-fluorouracil to inhibit colon cancer cell growth in vitro and in vivo
|
Tumber, Anthony
|
|
2006
|
60 |
2 |
p. 275-283
|
article
|
| 33 |
Tissue distribution in mice and metabolism in murine and human liver of apigenin and tricin, flavones with putative cancer chemopreventive properties
|
Cai, Hong
|
|
|
60 |
2 |
p. 257-266
|
article
|
| 34 |
Tissue distribution in mice and metabolism in murine and human liver of apigenin and tricin, flavones with putative cancer chemopreventive properties
|
Cai, Hong
|
|
2006
|
60 |
2 |
p. 257-266
|
article
|
Journal description